Literature DB >> 16374380

Human endotoxemia: a model for mechanistic insight and therapeutic targeting.

Stephen F Lowry1.   

Abstract

The diversity of phenotypic manifestations, comorbidities, and therapeutic algorithms in patients with severe inflammation have confounded efforts to translate mechanistic insights from the bench top to the bedside. This dilemma has negatively impacted upon many therapeutic interventions that exhibited seemingly well-reasoned preclinical portfolios. Prudence urges the assessment of potent immunoregulatory therapies, wherever possible, in models that replicate the clinical phenotype absent overt manifestations of genetically or environmentally modified processes. The healthy human model of endotoxin administration (systemic or endobronchial) provides such an opportunity and has been used to great advantage for gaining insight into mechanisms of disease and for determination of therapeutic signal strength. When thoughtfully interpreted, the model may provide proof of principle as well as lessen the unpredictability of clinical responses. Although the broad characteristics of this model are well described in the literature, it is recognized that this model does not fully replicate the magnitude of initial inflammatory stress nor the latent spectrum of inflammation/sepsis-inducible organ system pathologies. Nevertheless, the similarities between the early, transient clinical phenotype, inducible physiochemical change, and biochemical pathway activation of this model to the early hyperdynamic phase of resuscitated injury and infection are striking. Rational testing of a therapeutic mechanism requires a quantifiable and reproducibly altered marker of the hypothetical mechanism. Given the modest nature of endotoxin induced insult, interventions that demonstrate target specific efficacy in conjunction with attenuated phenotype responses are more likely to exhibit efficacy within lower risk patient populations. By contrast, the model cannot predict clinical efficacy among higher risk patients nor in those who have endured extended periods of inflammatory stress.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16374380     DOI: 10.1097/01.shk.0000191340.23907.a1

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  54 in total

1.  On heart rate variability and autonomic activity in homeostasis and in systemic inflammation.

Authors:  Jeremy D Scheff; Benjamin Griffel; Siobhan A Corbett; Steve E Calvano; Ioannis P Androulakis
Journal:  Math Biosci       Date:  2014-03-26       Impact factor: 2.144

2.  APOε4 is associated with enhanced in vivo innate immune responses in human subjects.

Authors:  Stephen C Gale; Li Gao; Carmen Mikacenic; Susette M Coyle; Nicholas Rafaels; Tanda Murray Dudenkov; Jennifer H Madenspacher; David W Draper; William Ge; Jim J Aloor; Kathleen M Azzam; Lihua Lai; Perry J Blackshear; Steven E Calvano; Kathleen C Barnes; Stephen F Lowry; Siobhan Corbett; Mark M Wurfel; Michael B Fessler
Journal:  J Allergy Clin Immunol       Date:  2014-03-18       Impact factor: 10.793

3.  Nicotine exposure alters in vivo human responses to endotoxin.

Authors:  X Wittebole; S Hahm; S M Coyle; A Kumar; S E Calvano; S F Lowry
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 4.  A critical review of human endotoxin administration as an experimental paradigm of depression.

Authors:  Nicole DellaGioia; Jonas Hannestad
Journal:  Neurosci Biobehav Rev       Date:  2009-08-08       Impact factor: 8.989

5.  Modeling autonomic regulation of cardiac function and heart rate variability in human endotoxemia.

Authors:  Jeremy D Scheff; Panteleimon D Mavroudis; Steven E Calvano; Stephen F Lowry; Ioannis P Androulakis
Journal:  Physiol Genomics       Date:  2011-06-14       Impact factor: 3.107

6.  Pretreatment with stress cortisol enhances the human systemic inflammatory response to bacterial endotoxin.

Authors:  Mark P Yeager; Athos J Rassias; Patricia A Pioli; Michael L Beach; Kathleen Wardwell; Jane E Collins; Hong-Kee Lee; Paul M Guyre
Journal:  Crit Care Med       Date:  2009-10       Impact factor: 7.598

7.  Metastatic-promoting effects of LPS: sexual dimorphism and mediation by catecholamines and prostaglandins.

Authors:  Ranit Naor; Vered Domankevich; Shaily Shemer; Luba Sominsky; Ella Rosenne; Ben Levi; Shamgar Ben-Eliyahu
Journal:  Brain Behav Immun       Date:  2008-10-08       Impact factor: 7.217

8.  In vivo endotoxin synchronizes and suppresses clock gene expression in human peripheral blood leukocytes.

Authors:  Beatrice Haimovich; Jacqueline Calvano; Adrian D Haimovich; Steve E Calvano; Susette M Coyle; Stephen F Lowry
Journal:  Crit Care Med       Date:  2010-03       Impact factor: 7.598

9.  Exploring the boundaries of systemic inflammation*.

Authors:  Jason M Elinoff; Anthony F Suffredini
Journal:  Crit Care Med       Date:  2014-07       Impact factor: 7.598

10.  Influence of acute epinephrine infusion on endotoxin-induced parameters of heart rate variability: a randomized controlled trial.

Authors:  Badar U Jan; Susette M Coyle; Leo O Oikawa; Shou-En Lu; Steve E Calvano; Paul M Lehrer; Stephen F Lowry
Journal:  Ann Surg       Date:  2009-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.